{
  "$type": "site.standard.document",
  "bskyPostRef": {
    "cid": "bafyreiganggaepauwpj54h4ohklm2vx3dkrlazpgejgypz73crw3whj5xi",
    "uri": "at://did:plc:5ka4qkui7nvjms7idhte2m4o/app.bsky.feed.post/3mgtiagubk7i2"
  },
  "coverImage": {
    "$type": "blob",
    "ref": {
      "$link": "bafkreiejif7qxtpsp6nmy3qekqnvvd2swkuxv2wfvmgjrr22fjc2nmznrq"
    },
    "mimeType": "image/jpeg",
    "size": 150743
  },
  "path": "/2026/03/11/biotech-news-fda-approves-leucovorin-for-rare-disorder/?utm_campaign=rss",
  "publishedAt": "2026-03-11T14:16:55.000Z",
  "site": "https://www.statnews.com",
  "tags": [
    "Biotech",
    "Business",
    "Pharma",
    "The Readout",
    "biotechnology",
    "drug development",
    "Drug prices",
    "research"
  ],
  "textContent": "How Jeffrey Epstein's friend came back to biotech, probes into the FDA's drug rejections, and other biotech news",
  "title": "STAT+: FDA approves leucovorin for rare disorder without trial data",
  "updatedAt": "2026-03-11T14:16:59.000Z"
}